These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25205625)

  • 1. Central CRF2 receptor antagonism reduces anxiety states during amphetamine withdrawal.
    Reinbold ED; Scholl JL; Oliver KM; Watt MJ; Forster GL
    Neurosci Res; 2014 Dec; 89():37-43. PubMed ID: 25205625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism.
    Vuong SM; Oliver HA; Scholl JL; Oliver KM; Forster GL
    Behav Brain Res; 2010 Mar; 208(1):278-81. PubMed ID: 19958793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.
    Huang MM; Overstreet DH; Knapp DJ; Angel R; Wills TA; Navarro M; Rivier J; Vale W; Breese GR
    J Pharmacol Exp Ther; 2010 Jan; 332(1):298-307. PubMed ID: 19843974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic amphetamine treatment enhances corticotropin-releasing factor-induced serotonin release in the amygdala.
    Scholl JL; Vuong SM; Forster GL
    Eur J Pharmacol; 2010 Oct; 644(1-3):80-7. PubMed ID: 20655906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior.
    Fu Y; Neugebauer V
    J Neurosci; 2008 Apr; 28(15):3861-76. PubMed ID: 18400885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors.
    Overstreet DH; Knapp DJ; Breese GR
    Pharmacol Biochem Behav; 2004 Feb; 77(2):405-13. PubMed ID: 14751471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic-like effects of antisauvagine-30 in mice are not mediated by CRF2 receptors.
    Zorrilla EP; Roberts AJ; Rivier JE; Koob GF
    PLoS One; 2013; 8(8):e63942. PubMed ID: 24015170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of lateral septum CRF2 receptors promotes anorexia and stress-like behaviors: functional homology to CRF1 receptors in basolateral amygdala.
    Bakshi VP; Newman SM; Smith-Roe S; Jochman KA; Kalin NH
    J Neurosci; 2007 Sep; 27(39):10568-77. PubMed ID: 17898228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus.
    Tanahashi S; Yamamura S; Nakagawa M; Motomura E; Okada M
    Psychopharmacology (Berl); 2012 Apr; 220(3):599-610. PubMed ID: 21947356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation.
    Valdez GR; Sabino V; Koob GF
    Alcohol Clin Exp Res; 2004 Jun; 28(6):865-72. PubMed ID: 15201629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior.
    Heinrichs SC; Lapsansky J; Lovenberg TW; De Souza EB; Chalmers DT
    Regul Pept; 1997 Jul; 71(1):15-21. PubMed ID: 9299637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar effect of CRF
    Spinieli RL; Leite-Panissi CRA
    Brain Res Bull; 2018 Mar; 137():187-196. PubMed ID: 29246866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine treatment increases corticotropin-releasing factor receptors in the dorsal raphe nucleus.
    Pringle RB; Mouw NJ; Lukkes JL; Forster GL
    Neurosci Res; 2008 Sep; 62(1):62-5. PubMed ID: 18585412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
    Staub DR; Evans AK; Lowry CA
    Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats.
    Zhao Y; Valdez GR; Fekete EM; Rivier JE; Vale WW; Rice KC; Weiss F; Zorrilla EP
    J Pharmacol Exp Ther; 2007 Dec; 323(3):846-54. PubMed ID: 17855476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats.
    Qi X; Guzhva L; Yang Z; Febo M; Shan Z; Wang KKW; Bruijnzeel AW
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1378-1389. PubMed ID: 27461514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in striatal dopamine release and locomotor activity following acute withdrawal from chronic nicotine are mediated by CRF1, but not CRF2, receptors.
    Buzás A; Bokor P; Balangó B; Pintér D; Palotai M; Simon B; Csabafi K; Telegdy G; Szabó G; Bagosi Z
    Brain Res; 2019 Mar; 1706():41-47. PubMed ID: 30722977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor receptor antagonism within the dorsal raphe nucleus reduces social anxiety-like behavior after early-life social isolation.
    Lukkes J; Vuong S; Scholl J; Oliver H; Forster G
    J Neurosci; 2009 Aug; 29(32):9955-60. PubMed ID: 19675229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain.
    Tran L; Schulkin J; Greenwood-Van Meerveld B
    Neuropsychopharmacology; 2014 Oct; 39(11):2633-45. PubMed ID: 24853772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.